Public Health Emergency - Leading a Nation Prepared
On March 19, 2020, FDA issued an Emergency Use Authorization (EUA) to allow DiaSorin Molecular LLC’s Simplexa COVID-19 Direct Assay to be used to diagnose COVID-19.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages